Sam Testing - Donate - [STAGING] Peter MacCallum Cancer Foundation

Skip to main content ( press enter )

Sam Testing - Donate

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

@Follow us on Instagram (@SupportPeterMac)

This cancer type is rare, which makes it hard to study. But researchers at Peter Mac know how to tackle it. 🤝 For sarcoma and other rare cancers, collaboration is key. When cancers are rare, there are too few patients in one place. This means few clinical trials to learn from. Not enough evidence to guide the best way forward. Professor David Gyorki is passionate about changing this. Prof Gyorki connects cancer centres around the world to improve treatments for sarcomas. The researchers share knowledge, compare results, and build the evidence. 💬 “Because it's a group of rare cancers, we have this group of global sarcoma experts all with a commitment to improving outcomes. We're dedicated to learning from each other,” says Prof Gyorki. Every study, every trial, every shared dataset adds to our understanding of how to stop cancer sooner. Cancer research is a worldwide effort. Through Peter Mac, you can help. Read more: foundation.petermac.org/profdavidgyorki

For International Women’s Day 2026, we celebrate all the outstanding women in research at Peter Mac. The Peter MacCallum Cancer Foundation established the annual Lea Medal ten years ago to support women in the early to mid-stage of their research careers. Women awarded the Lea Medal receive $50,000 to both pursue important cancer research and continue developing as researchers and leaders during this crucial time in their careers. This year, the Lea Medal was awarded to Dr Aparna Rao, Dr Deborah Meyran and Associate Professor Safeera Hussainy. To read more about their incredible research initiatives – which were enabled by our generous donors – head to the link in bio.

Understanding how ovarian cancer treatment succeeds or fails may be the key to improving outcomes for this devastating disease. This Ovarian Cancer Awareness Month, we acknowledge the many women and families who have faced ovarian cancer. The deadliest cancer affecting Australian women, nearly half of all women diagnosed with ovarian cancer sadly do not survive. New treatment approaches are urgently needed. We’re proud to spotlight the Bowtell Lab at Peter Mac and its work to transform ovarian cancer outcomes, by uncovering how treatment resistance develops, what drives long-term survival, and advocating for genetic testing. Learn more about our research to improve the landscape of ovarian cancer treatment and bring new hope for women diagnosed at the link in bio.

Could exercise be part of the key to managing the significant side effects of an innovative blood cancer treatment? Although CAR T-cell therapy has been revolutionary in blood cancer treatment, it is associated with significant symptoms such as pain, extreme fatigue, confusion and difficulty walking. Exercise has been shown to help manage symptoms and improve physical function for people receiving other blood cancer treatments, but we don’t yet know how effective it is for patients receiving CAR T-cell therapy. As the number of patients with cancer receiving CAR T-cell therapy continues to grow, Peter Mac researcher and Foundation Grant recipient Associate Professor Lara Edbrooke is eager to explore if exercise can help these patients manage the unpleasant side effects. Using a remotely-delivered exercise intervention, Associate Professor Edbrooke will study changes in patients’ exercise and behaviour before and after they receive CAR T-cell therapy. The intervention will include supervised exercise to manage symptoms and improve physical function, and strategies to help sustain long-term exercise. This research – the first of its kind in Australia – can potentially create valuable knowledge that improves the experience of patients with blood cancer being treated with CAR T-cell therapy. Thank you for supporting research that finds new ways to improve care and treatment for people with cancer.

We are delighted to share with you the new Peter Mac Foundation’s strategy! Every day, people affected by cancer face some of the toughest moments of their lives. Support from our incredible community helps make world-leading research, innovative treatments and compassionate care possible. Our new strategy sets forward how your generosity will continue to make a real difference for patients and families, today and into the future. By working closely with Peter Mac, we’re ensuring your support drives the breakthroughs that matter most. Together, we’re helping shape the future of cancer care and research – and creating hope where it’s needed most. Thank you for being part of this journey. To read our new strategy, head to the link in bio.

This World Cancer Day 2026, we are United by Unique. We often hear from our incredible community of Peter Mac supporters about their personal journeys with cancer. And every story we hear reminds us that no two cancer journeys are the same. These stories show us why research into personalised cancer care is so vital. Cancer doesn’t affect people in one way, and the best treatment recognises and responds to each person’s uniqueness. That’s why Peter Mac’s researchers are developing therapies shaped by each person’s needs, keeping people at the heart of all we do. Today, we recognise all Peter Mac supporters and the many different experiences and motivations that unite them. Thank you for helping advance cancer treatment and care shaped around each individual.